The agency, in its latest update released Thursday, said the mutations were not found in samples taken from wild birds, suggesting the virus changed over the course of the patient’s infection.
Hosted on MSN55m
Bristol Myers Squibb Stock In Focus After FDA Approves Cancer Drug: Retail Sentiment BrightensShares of Bristol Myers Squibb ($BMY) were in the spotlight on Friday after the U.S. Food and Drug Administration approved an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback